Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
32.6M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
16.8M
-
Shares change
-
-526K
-
Total reported value, excl. options
-
$67.4M
-
Value change
-
-$1.67M
-
Number of buys
-
26
-
Number of sells
-
-34
-
Price
-
$4.02
Significant Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q3 2025
85 filings reported holding ANRO - Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.8M shares
of 32.6M outstanding shares and own 51.47% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (3.71M shares), ARMISTICE CAPITAL, LLC (1.64M shares), Point72 Asset Management, L.P. (1.33M shares), FRANKLIN RESOURCES INC (1.16M shares), VANGUARD GROUP INC (1.11M shares), Vestal Point Capital, LP (950K shares), MARSHALL WACE, LLP (825K shares), 72 Investment Holdings, LLC (668K shares), ALKEON CAPITAL MANAGEMENT LLC (477K shares), and NORTHERN TRUST CORP (461K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.